FIRST HEARTLAND CONSULTANTS, INC. – First Trust NYSE Arca Biotechnology Index Fund Transaction History
FIRST HEARTLAND CONSULTANTS, INC. portfolio value:
$753,000
portfolio value
FIRST HEARTLAND CONSULTANTS, INC. quarter portfolio value change:
-2.64%
quarter
First Trust NYSE Arca Biotechnology Index Fund 13F transactions
| Quarter | Transaction type | Change | Relative change | Absolute change | Change value | Avg. price | Shares |
|---|---|---|---|---|---|---|---|
| Q3 2022 | share | Decrease | -5.93% | -360 shares | -69K | $131.98 | 5.71K |
| Q2 2022 | share | Decrease | -2.16% | -134 shares | -103K | $135.56 | 6.07K |
| Q1 2022 | share | Decrease | -24.75% | -2.04K shares | -410K | $149.14 | 6.20K |
| Q4 2021 | share | Decrease | -20.45% | -2.11K shares | -386K | $163.12 | 8.24K |
| Q3 2021 | share | Decrease | -43.79% | -8.07K shares | -1.46M | $166.07 | 10.36K |
| Q2 2021 | share | Decrease | -1.90% | -358 shares | 166K | $172.62 | 18.43K |
| Q1 2021 | share | Decrease | -6.17% | -1.23K shares | -348K | $160.5 | 18.79K |
| Q4 2020 | share | Increase | +7.65% | 1.42K shares | 439K | $167.99 | 20.03K |
| Q3 2020 | share | Increase | +10.33% | 1.74K shares | 97K | $157.26 | 18.60K |
| Q2 2020 | share | Increase | +523.01% | 14.15K shares | 2.47M | $167.77 | 16.86K |
| Q1 2020 | share | Increase | 0.00% | 2.70K shares | 355K | $131.12 | 2.70K |
| Q4 2019 | share | Decrease | -100.00% | -4.00K shares | -496K | $148.72 | 0 |
| Q3 2019 | share | Increase | +10.21% | 371 shares | -16K | $123.77 | 4.00K |
| Q2 2019 | share | Increase | +49.47% | 1.20K shares | 145K | $140.84 | 3.63K |
| Q1 2019 | share | Increase | 0.00% | 2.43K shares | 367K | $150.85 | 2.43K |
| Q4 2016 | share | Decrease | -100.00% | -16.05K shares | -1.6M | $90.88 | 0 |
| Q3 2016 | share | Increase | +200.92% | 10.71K shares | 1.12M | $99.71 | 16.05K |
| Q2 2016 | share | Decrease | -30.51% | -2.34K shares | -195K | $89.44 | 5.33K |
| Q1 2016 | share | Decrease | -64.74% | -14.09K shares | -1.78M | $87.56 | 7.67K |